Section 1 Short title
This Act may be cited as the “Protecting Life and Integrity in Research Act of 2025”.
Protecting Life and Integrity in Research Act of 2025
A BILL
To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.
Sec. 2 No research involving human fetal tissue obtained pursuant to an induced abortion
In general—
In general— No Federal department, agency, or office may conduct, fund, approve, or otherwise support any research involving human fetal tissue that is obtained pursuant to an induced abortion.
Development of new, ethical cell lines— Subsection (a) does not limit the authority of any Federal department, agency, or office to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion.
Research involving human fetal tissue obtained after a miscarriage or stillbirth permitted— Any research of any Federal department, agency, or office on human fetal tissue obtained after a miscarriage or stillbirth shall be conducted or supported in accordance with section 498A of the Public Health Service Act (42 U.S.C. 289g–1).
Amendments to the PHSA limiting human fetal tissue research to tissue obtained after a miscarriage or stillbirth— Section 498A of the Public Health Service Act (42 U.S.C. 289g–1) is amended—
in the section heading, by striking “transplantation of fetal tissue” and inserting “human fetal tissue obtained after a miscarriage or stillbirth”;
by amending subsection (a) to read as follows:
“(a) Establishment of program—The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.”
in subsection (b)—
in paragraph (1)(B), by inserting “if the human fetal tissue is intended for transplantation,” before “the donation”; and
in paragraph (2)—
by striking subparagraph (A); and
by redesignating subparagraphs (B) and (C) as (A) and (B), respectively;
in subsection (c)(1)(B), by striking “pursuant to a spontaneous or induced abortion or pursuant to” and inserting “after a miscarriage or”; and
by amending subsection (g) to read as follows:
“(g) Definitions—In this section:
“(1) Human fetal tissue—The term “human fetal tissue” means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth.
“(2) Miscarriage—The term “miscarriage” means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks.
“(3) Stillbirth—The term “stillbirth” means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more.
“(4) Unborn child—The term “unborn child” has the meaning given such term in section 1841(d) of title 18, United States Code.”
Conforming repeal— Section 113 of the National Institutes of Health Revitalization Act of 1993 (42 U.S.C. 289g–1 note) is repealed.
Sec. 3 Prohibition against solicitation or knowing acquisition, receipt, or acceptance of a donation of human fetal tissue knowing that the tissue was obtained pursuant to an induced abortion
In general— Section 498B(c)(1) of the Public Health Service Act (42 U.S.C. 289g–2(c)(1)) is amended to read as follows:
“(1) solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—
“(A) a human pregnancy was deliberately initiated to provide such tissue; or
“(B) the tissue was obtained pursuant to an induced abortion; or”
Conforming changes— Section 498B of the Public Health Service Act (42 U.S.C. 289g–2), as amended by subsection (a), is further amended—
by striking subsection (b);
by redesignating subsections (c) through (e) as subsections (b) through (d), respectively; and
in subsection (c), as redesignated—
in paragraph (1), by striking “(a), (b), or (c)” and inserting “(a) or (b)”; and
in paragraph (2), by striking “or (b)(3)”.